Evidence map›Paper›PMID 37273534›Full record

ArticlePeerJ2023

The significance of PD-1/PD-L1 imbalance in ulcerative colitis.

Wei Shi, Yu Zhang, Chonghua Hao, Xiaofeng Guo, Qin Yang, Junfang Du, Yabin Hou, Gaigai Cao, Jingru Li, Haijiao Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Notch2-expressing CD4Cellular & molecular immunology · 2025
    Article
  4. Expression of sPD-L1 levels in an ex vivo liver perfusion model.Clinical and experimental immunology · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Wei Shi *Department of Clinical Laboratory, Shanxi Provincial People's Hospital, Taiyuan, China.
Yu Zhang *The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Chonghua HaoThe Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Xiaofeng GuoDepartment of Gastroenterology, Shanxi Provincial People's Hospital, Taiyuan, China.
Qin YangDepartment of Pathology, Shanxi Provincial People's Hospital, Taiyuan, China.
Junfang DuDepartment of Clinical Laboratory, Shanxi Provincial People's Hospital, Taiyuan, China.
Yabin HouThe Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Gaigai CaoThe Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Jingru LiThe Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Haijiao WangShanxi Center for Disease Control and Prevention, Taiyuan, China.
Wei FangDepartment of Clinical Laboratory, Shanxi Provincial People's Hospital, Taiyuan, China.
Shanxi Medical University · CNShaanxi Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To investigate the expression and significance of programmed cell death protein 1 (PD-1) and programmed cell death ligand-1 (PD-L1) in the mucosal tissues and peripheral blood of patients with ulcerative colitis (UC). Methods: Eighty patients with UC were recruited from January 2021 to August 2022 from the Shanxi Province People's Hospital. PD-1 and PD-L1 expression was assessed by immunohistochemistry in mucosal tissues. An enzyme-linked immunosorbent assay was used to measure soluble PD-1 and PD-L1 levels in peripheral blood serum, and the membrane-bound forms of PD-1 (mPD-1), (T-helper cell) Th1 and Th17, in peripheral blood were determined by flow cytometry. Result: PD-1 expression was observed only in the monocytes of the mucosal lamina propria of UC patients, while PD-L1 was mainly located in both epithelial cells and monocytes on the cell membrane. The expression level of PD-1/PD-L1 in the monocytes and epithelial cells of mucosal lamina propria increased with disease activity ( Conclusion: The expression level of PD-1/PD-L1 was correlated with UC disease activity, and two forms of PD-1 and PD-L1 may be used as a potential marker for predicting UC and assessing disease progression in UC patients. PD-1/PD-L1 imbalance was a significant phenomenon of UC immune dysfunction. Future research should focus on two forms of PD-1/PD-L1 signaling molecules to better understand the pathogenesis of UC and to identify potential drug therapies.

Indexed as

Colitis, UlcerativeB7-H1 AntigenEnzyme-Linked Immunosorbent AssayHumansLigandsProgrammed Cell Death 1 ReceptorB7-H1 AntigenLigandsProgrammed Cell Death 1 ReceptorDisease activityProgrammed cell death-1 (PD-1)Programmed cell death ligand-1 (PD-L1)Ulcerative colitis

Identifiers

PMID37273534
PMCPMC10239227
OpenAlexW4378901363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.